Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 17,967Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Coral Drugs Private Limited

02 1VAMSI LABS LIMITED.

03 1Farmabios S.p.A.

04 1Wavelength Enterprises LTD

05 1Symbiotec Pharmalab Private Limited

06 1Aarti Pharmalabs Limited

07 1Amphastar Nanjing Pharmaceuticals, Inc.

08 1Aurisco Pharmaceutical Co.,Ltd

09 1Cipla Ltd.

10 1Curia Spain S.A.U.

11 1Fagron Inc

12 1Glaxo Operations UK Ltd

13 1Glaxo Wellcome Manufacturing Pte. Ltd

14 1Hikma Pharmaceuticals LLC

15 1Hovione FarmaCiencia SA

16 1Hovione PharmaScience Limited

17 3Industriale Chimica s.r.l.

18 1LETCO MEDICAL, LLC

19 1Medisca Inc

20 1NEWCHEM SPA

21 1Professional Compounding Centers of America dba PCCA

22 1STERLING SPA

23 1Sicor de Mexico S.A. de C.V

24 2Sterling S.p.A.

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BIO Partnering at JPM
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCoral's API range includes Corticosteroids, Antihistamines. Hormones and Antineoplastics.

FLUTICASONE PROPIONATE

NDC Package Code : 49076-5501

Start Marketing Date : 2018-10-26

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Corel Drugs cGMP partner for APIs

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

FLUTICASONE PROPIONATE-17.BETA.-CARBOXYLIC ACID

NDC Package Code : 66412-0679

Start Marketing Date : 2023-09-25

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

Vamsi Labs

03

arrow
BIO Partnering at JPM
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAxplora- The partner of choice for complex APIs.

FLUTICASONE PROPIONATE

NDC Package Code : 46439-8729

Start Marketing Date : 2007-04-24

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

Axplora CB

04

arrow
BIO Partnering at JPM
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

FLUTICASONE PROPIONATE

NDC Package Code : 58175-0361

Start Marketing Date : 2000-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

Seqens Company Banner

05

arrow
BIO Partnering at JPM
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSymbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.

FLUTICASONE PROPIONATE

NDC Package Code : 22552-0043

Start Marketing Date : 2015-01-07

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

Symbiotec Pharmalab

06

arrow
BIO Partnering at JPM
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.

FLUTICASONE PROPIONATE

NDC Package Code : 15308-0200

Start Marketing Date : 2005-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Aarti Industries Company Banner

07

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

FLUTICASONE PROPIONATE

NDC Package Code : 16812-005

Start Marketing Date : 2022-01-07

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

09

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

FLUTICASONE PROPIONATE

NDC Package Code : 38779-2760

Start Marketing Date : 2014-05-27

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

10

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

FLUTICASONE PROPIONATE

NDC Package Code : 24002-0003

Start Marketing Date : 2009-08-10

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

Flixotide Inhaler Manufacturers

A Flixotide Inhaler manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flixotide Inhaler, including repackagers and relabelers. The FDA regulates Flixotide Inhaler manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flixotide Inhaler API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Flixotide Inhaler manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Flixotide Inhaler Suppliers

A Flixotide Inhaler supplier is an individual or a company that provides Flixotide Inhaler active pharmaceutical ingredient (API) or Flixotide Inhaler finished formulations upon request. The Flixotide Inhaler suppliers may include Flixotide Inhaler API manufacturers, exporters, distributors and traders.

click here to find a list of Flixotide Inhaler suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Flixotide Inhaler NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Flixotide Inhaler as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Flixotide Inhaler API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Flixotide Inhaler as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Flixotide Inhaler and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Flixotide Inhaler NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Flixotide Inhaler suppliers with NDC on PharmaCompass.

Flixotide Inhaler Manufacturers | Traders | Suppliers

Flixotide Inhaler Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.